From personalised medicine and disease diagnosis to drug development and digital health products and devices, the application of AI in life sciences is advancing at an incredibly rapid rate. In-house teams need to stay on top of ethical, commercial and legislative issues to realise AI's potential while avoiding regulatory and reputational risks.
The full agenda is available on the website here. Our insightful sessions will be followed by a drinks reception from 4:30pm – we hope you'll be able to join us.
